Literature DB >> 26385475

Discovery of a Potent Allosteric Kinase Modulator by Combining Computational and Synthetic Methods.

Edwin Kroon1, Jörg O Schulze2, Evelyn Süß2, Carlos J Camacho3, Ricardo M Biondi2, Alexander Dömling4.   

Abstract

The rational design of allosteric kinase modulators is challenging but rewarding. The protein kinase PDK1, which lies at the center of the growth-factor signaling pathway, possesses an allosteric regulatory site previously validated both in vitro and in cells. ANCHOR.QUERY software was used to discover a potent allosteric PDK1 kinase modulator. Using a recently published PDK1 compound as a template, several new scaffolds that bind to the allosteric target site were generated and one example was validated. The inhibitor can be synthesized in one step by multicomponent reaction (MCR) chemistry when using the ANCHOR.QUERY approach. Our results are significant because the outlined approach allows rapid and efficient scaffold hopping from known molecules into new easily accessible and biologically active ones. Based on increasing interest in allosteric-site drug discovery, we foresee many potential applications for this approach.
© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  inhibitors; kinases; pharmacophores; protein-protein interaction; virtual screening

Mesh:

Substances:

Year:  2015        PMID: 26385475      PMCID: PMC4721676          DOI: 10.1002/anie.201506310

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  35 in total

1.  Systematic investigation of halogen bonding in protein-ligand interactions.

Authors:  Leo A Hardegger; Bernd Kuhn; Beat Spinnler; Lilli Anselm; Robert Ecabert; Martine Stihle; Bernard Gsell; Ralf Thoma; Joachim Diez; Jörg Benz; Jean-Marc Plancher; Guido Hartmann; David W Banner; Wolfgang Haap; François Diederich
Journal:  Angew Chem Int Ed Engl       Date:  2011-01-03       Impact factor: 15.336

2.  Exhaustive fluorine scanning toward potent p53-Mdm2 antagonists.

Authors:  Yijun Huang; Siglinde Wolf; David Koes; Grzegorz M Popowicz; Carlos J Camacho; Tad A Holak; Alexander Dömling
Journal:  ChemMedChem       Date:  2011-09-27       Impact factor: 3.466

3.  Allosteric activation of the protein kinase PDK1 with low molecular weight compounds.

Authors:  Matthias Engel; Valerie Hindie; Laura A Lopez-Garcia; Adriana Stroba; Francis Schaeffer; Iris Adrian; Jochen Imig; Leila Idrissova; Wolfgang Nastainczyk; Stefan Zeuzem; Pedro M Alzari; Rolf W Hartmann; Albrecht Piiper; Ricardo M Biondi
Journal:  EMBO J       Date:  2006-11-16       Impact factor: 11.598

Review 4.  Emerging paradigms in GPCR allostery: implications for drug discovery.

Authors:  Denise Wootten; Arthur Christopoulos; Patrick M Sexton
Journal:  Nat Rev Drug Discov       Date:  2013-08       Impact factor: 84.694

5.  Structure and allosteric effects of low-molecular-weight activators on the protein kinase PDK1.

Authors:  Valerie Hindie; Adriana Stroba; Hua Zhang; Laura A Lopez-Garcia; Leila Idrissova; Stefan Zeuzem; Daniel Hirschberg; Francis Schaeffer; Thomas J D Jørgensen; Matthias Engel; Pedro M Alzari; Ricardo M Biondi
Journal:  Nat Chem Biol       Date:  2009-08-30       Impact factor: 15.040

6.  Substrate-selective inhibition of protein kinase PDK1 by small compounds that bind to the PIF-pocket allosteric docking site.

Authors:  Katrien Busschots; Laura A Lopez-Garcia; Carmen Lammi; Adriana Stroba; Stefan Zeuzem; Albrecht Piiper; Pedro M Alzari; Sonja Neimanis; Jose M Arencibia; Matthias Engel; Jörg O Schulze; Ricardo M Biondi
Journal:  Chem Biol       Date:  2012-09-21

7.  Robust generation of lead compounds for protein-protein interactions by computational and MCR chemistry: p53/Hdm2 antagonists.

Authors:  Anna Czarna; Barbara Beck; Stuti Srivastava; Grzegorz M Popowicz; Siglinde Wolf; Yijun Huang; Michal Bista; Tad A Holak; Alexander Dömling
Journal:  Angew Chem Int Ed Engl       Date:  2010-07-19       Impact factor: 15.336

8.  The PIF-binding pocket in PDK1 is essential for activation of S6K and SGK, but not PKB.

Authors:  R M Biondi; A Kieloch; R A Currie; M Deak; D R Alessi
Journal:  EMBO J       Date:  2001-08-15       Impact factor: 11.598

9.  Turning a protein kinase on or off from a single allosteric site via disulfide trapping.

Authors:  Jack D Sadowsky; Mark A Burlingame; Dennis W Wolan; Christopher L McClendon; Matthew P Jacobson; James A Wells
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-23       Impact factor: 11.205

10.  3,5-Diphenylpent-2-enoic acids as allosteric activators of the protein kinase PDK1: structure-activity relationships and thermodynamic characterization of binding as paradigms for PIF-binding pocket-targeting compounds.

Authors:  Adriana Stroba; Francis Schaeffer; Valerie Hindie; Laura Lopez-Garcia; Iris Adrian; Wolfgang Fröhner; Rolf W Hartmann; Ricardo M Biondi; Matthias Engel
Journal:  J Med Chem       Date:  2009-08-13       Impact factor: 7.446

View more
  8 in total

1.  Novel Compounds Targeting the RNA-Binding Protein HuR. Structure-Based Design, Synthesis, and Interaction Studies.

Authors:  Serena Della Volpe; Rita Nasti; Michele Queirolo; M Yagiz Unver; Varsha K Jumde; Alexander Dömling; Francesca Vasile; Donatella Potenza; Francesca Alessandra Ambrosio; Giosué Costa; Stefano Alcaro; Chiara Zucal; Alessandro Provenzani; Marcello Di Giacomo; Daniela Rossi; Anna K H Hirsch; Simona Collina
Journal:  ACS Med Chem Lett       Date:  2019-01-21       Impact factor: 4.345

2.  AnchorQuery: Rapid online virtual screening for small-molecule protein-protein interaction inhibitors.

Authors:  David R Koes; Alexander Dömling; Carlos J Camacho
Journal:  Protein Sci       Date:  2017-10-24       Impact factor: 6.725

Review 3.  Inhibitors of protein-protein interactions (PPIs): an analysis of scaffold choices and buried surface area.

Authors:  Xu Ran; Jason E Gestwicki
Journal:  Curr Opin Chem Biol       Date:  2018-06-13       Impact factor: 8.822

Review 4.  Tetrazoles via Multicomponent Reactions.

Authors:  Constantinos G Neochoritis; Ting Zhao; Alexander Dömling
Journal:  Chem Rev       Date:  2019-02-01       Impact factor: 60.622

5.  Identification of small molecule inhibitors of the Aurora-A/TPX2 complex.

Authors:  Italia Anna Asteriti; Frederick Daidone; Gianni Colotti; Serena Rinaldo; Patrizia Lavia; Giulia Guarguaglini; Alessandro Paiardini
Journal:  Oncotarget       Date:  2017-05-09

6.  Enantiomeric Resolution and Absolute Configuration of a Chiral δ-Lactam, Useful Intermediate for the Synthesis of Bioactive Compounds.

Authors:  Roberta Listro; Giacomo Rossino; Serena Della Volpe; Rita Stabile; Massimo Boiocchi; Lorenzo Malavasi; Daniela Rossi; Simona Collina
Journal:  Molecules       Date:  2020-12-19       Impact factor: 4.411

7.  Rapid Discovery of Aspartyl Protease Inhibitors Using an Anchoring Approach.

Authors:  Markella Konstantinidou; Francesca Magari; Fandi Sutanto; Jörg Haupenthal; Varsha R Jumde; M Yagiz Ünver; Andreas Heine; Carlos Jamie Camacho; Anna K H Hirsch; Gerhard Klebe; Alexander Dömling
Journal:  ChemMedChem       Date:  2020-03-18       Impact factor: 3.540

8.  TEAD-YAP Interaction Inhibitors and MDM2 Binders from DNA-Encoded Indole-Focused Ugi Peptidomimetics.

Authors:  Verena B K Kunig; Marco Potowski; Mohammad Akbarzadeh; Mateja Klika Škopić; Denise Dos Santos Smith; Lukas Arendt; Ina Dormuth; Hélène Adihou; Blaž Andlovic; Hacer Karatas; Shabnam Shaabani; Tryfon Zarganes-Tzitzikas; Constantinos G Neochoritis; Ran Zhang; Matthew Groves; Stéphanie M Guéret; Christian Ottmann; Jörg Rahnenführer; Roland Fried; Alexander Dömling; Andreas Brunschweiger
Journal:  Angew Chem Int Ed Engl       Date:  2020-07-15       Impact factor: 16.823

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.